Invesco Ltd. (CRL) discloses 5.5% Charles River Labs holding

Rhea-AI Filing Summary

Invesco Ltd. has disclosed a significant ownership position in Charles River Laboratories International Inc. common stock. As of 12/31/2025, Invesco may be deemed to beneficially own 2,696,150 shares, representing 5.5% of the outstanding common shares, held for its investment advisory clients.

Invesco reports sole voting power over 2,686,062 shares and sole dispositive power over 2,696,150 shares, with no shared voting or dispositive power. The holdings are stated to be acquired and held in the ordinary course of business and not for the purpose of changing or influencing control of the company.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Charles River Laboratories International Inc

(Name of Issuer)

Common Stock

(Title of Class of Securities)

159864107

(CUSIP Number)

12/31/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 159864107

1

Names of Reporting Persons

Invesco Ltd.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

BERMUDA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 2,686,062.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 2,696,150.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,696,150.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.5 %

12

Type of Reporting Person (See Instructions)

HC, IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Charles River Laboratories International Inc
(b)	Address of issuer's principal executive offices: 251 Ballardvale Street, Wilmington, MA 01887
Item 2.
(a)	Name of person filing: Invesco Ltd. ("Invesco Ltd.")
(b)	Address or principal business office or, if none, residence: 1331 Spring Street NW, Suite 2500, Atlanta, GA 30309
(c)	Citizenship: Bermuda
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 159864107
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: Invesco Ltd., in its capacity as a parent holding company to its investment advisers, may be deemed to beneficially own 2,696,150 shares of the Issuer which are held of record by clients of Invesco Ltd.
(b)	Percent of class: 5.5 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 2,686,062
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 2,696,150
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. However, no one individual has greater than 5% economic ownership. The shareholders of the Fund have the right to receive or the power to direct the receipt of dividends and proceeds from the sale of securities listed above.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. Invesco Advisers, Inc. Invesco Management S.A. Invesco Capital Management LLC
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Invesco Ltd.

Signature:	Robert R. Leveille
Name/Title:	Global Head of Compliance
Date:	02/12/2026

FAQ

What ownership stake does Invesco report in Charles River Laboratories (CRL)?

Invesco Ltd. reports beneficial ownership of 2,696,150 shares of Charles River Laboratories common stock, representing 5.5% of the class as of December 31, 2025. These shares are held for clients of Invesco’s investment advisory subsidiaries.

How much voting power does Invesco have over CRL shares?

Invesco reports sole power to vote or direct the vote over 2,686,062 Charles River Laboratories shares and no shared voting power. This means voting decisions for these shares are controlled solely through Invesco’s advisory structure on behalf of its clients.

Who legally holds the Charles River Laboratories shares reported by Invesco?

The 2,696,150 Charles River Laboratories shares are held of record by clients of Invesco’s investment advisers. Invesco Ltd., as a parent holding company, may be deemed to beneficially own these shares through its advisory subsidiaries managing client accounts.

Is any single Invesco client a more than 5% owner of CRL?

No single client has more than 5% economic ownership of Charles River Laboratories’ common stock. The filing states that no individual has greater than 5% economic ownership, even though aggregate holdings managed by Invesco’s advisers total 5.5% of the class.

What is Invesco’s stated purpose for holding CRL shares?

Invesco certifies that the Charles River Laboratories shares were acquired and are held in the ordinary course of business. It further states they were not acquired and are not held to change or influence control of the company or as part of a control-related transaction.

Which Invesco subsidiaries are involved in managing the CRL position?

The filing identifies Invesco Advisers, Inc., Invesco Management S.A., and Invesco Capital Management LLC as relevant subsidiaries. These entities act as investment advisers whose client accounts hold the Charles River Laboratories shares that Invesco Ltd. may be deemed to beneficially own.